Feasibility and long-term outcomes of surgery for primary thoracic synovial sarcoma.

ABSTRACT:

Objectives

Primary thoracic synovial sarcoma (SS) is a rare, high-grade, malignancy. Involvement of vital organs is frequent and may decrease the benefits of surgical resection. We reviewed our practice at a highly experienced thoracic-surgery centre to assess early- and long-term outcomes after surgery.

Methods

We conducted a retrospective, observational, single-centre study of patients undergoing curative-intent surgery for primary thoracic SS between 1 January 2000 and 31 January 2021 as part of a multidisciplinary management. We assessed demographics, medical history, histopathology and follow-up information.

Results

We enrolled 20 patients (13 males) with a median age of 40 years old and a median tumour size of 11 cm. Neoadjuvant chemotherapy was administered to

SUBMITTER: Pieropan S 

PROVIDER: S-EPMC9492245 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature